Site of primary tumor has a prognostic role in operable breast cancer: The International Breast Cancer Study Group experience

Journal of Clinical Oncology

Volumn 23, Issue 7, 2005, Pages 1390-1400

  Colleoni, Marco ^a   Zahrieh, David ^b   Gelber, Richard D ^b   Holmberg, Stig B ^b   Mattsson, Jan E ^b   Rudenstam, Carl Magnus ^b   Lindtner, Jurij ^b   Eržen, Darja ^b   Snyder, Raymond ^b   Collins, John ^b   Fey, Martin F ^b   Thürlimann, Beat ^b   Crivellari, Diana ^b   Murray, Elizabeth ^b   Mendiola, Caesar ^b   Pagani, Olivia ^b   Castiglione Gertsch, Monica ^b   Coates, Alan S ^b   Price, Karen ^b   Goldhirsch, Aron ^b  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; FLUOROURACIL; METHOTREXATE; PREDNISONE; TAMOXIFEN;

ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; BREAST TUMOR; CANCER STAGING; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MULTIPLE CYCLE TREATMENT; OVARIECTOMY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; RELAPSE; TREATMENT DURATION; ADULT; AGED; AXILLA; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; FEMALE; LYMPH NODE; MIDDLE AGED; MORTALITY; PATHOLOGY; RANDOMIZED CONTROLLED TRIAL; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; AXILLA; BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPH NODES; MIDDLE AGED; PROGNOSIS; SURVIVAL RATE;

EID: 20144386511     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.06.052     Document Type: Article

References (27)

1. Goldhirsch A, Wood WC, Gelber RD, et al: Meeting highlights: Updated international expert consensus on the primary therapy of early breast cancer. J Clin Oncol 21:3357-3365, 2003
2. Zucali R, Mariani L, Marubini E, et al: Early breast cancer: Evaluation of the prognostic role of the site of the primary tumor. J Clin Oncol 16:1363-1366, 1998
3. Lohrisch C, Jackson J, Jones A, et al: Relationship between tumor location and relapse in 6,781 women with early invasive breast cancer. J Clin Oncol 18:2828-2835, 2000
4. Castiglione-Gertsch M, Johnsen C, Goldhirsch A, et al: The International Breast Cancer Study Group Trials I-IV: 15 years of follow-up. Ann Oncol 5:717-724, 1994
5. Ludwig Breast Cancer Study Group: Prolonged disease-free survival after one course of perioperative adjuvant chemotherapy for node-negative breast cancer. N Engl J Med 320:491-496, 1989
6. Ludwig Breast Cancer Study Group: Combination adjuvant chemotherapy for node-positive breast cancer: Inadequacy of a single perioperative cycle. N Engl J Med 319:677-683, 1988
7. International Breast Cancer Study Group: Duration and reintroduction of adjuvant chemotherapy for node-positive premenopausal breast cancer patients. J Clin Oncol 14:1885-1894, 1996
8. International Breast Cancer Study Group: Effectiveness of adjuvant chemotherapy in combination with tamoxifen for node-positive postmenopausal breast cancer patients. J Clin Oncol 15:1385-1394, 1997
9. International Breast Cancer Study Group (IBCSG): Endocrine responsiveness and tailoring adjuvant therapy for postmenopausal lymph node-negative breast cancer: A randomized trial. J Natl Cancer Inst 94:1054-1065, 2002
10. Cox R: Regression models and life tables (with discussion). J R Stat Soc B (Methodology) 34:187-220, 1972
11. Goldhirsch A, Gelber RD, Price KN, et al: Effect of systemic adjuvant treatment on first sites of breast cancer relapse. Lancet 343:377-381, 1994
12. Akaike H: A new look at the statistical model identification. IEEE Trans Automatic Control 19:716-723, 1974
13. Cox DR, Hinkley DV: Theoretical Statistics. New York, NY, Chapman and Hall, 1974
14. Veronesi U, Cascinelli N, Bufalino R, et al: Risk of internal mammary lymph node metastases and its relevance on prognosis of breast cancer patients. Ann Surg 198:681-684, 1983
15. Handley R: Natural history of breast cancer, in Harris J, Lippman ME, Morrow M, et al (eds): Diseases of the Breast. Philadelphia, PA, WB Saunders, 1996, pp 384
16. Urban J: Is there a rationale for an extended radical procedure? Int J Radiat Oncol Biol Phys 2:985-988, 1977
17. Lacour J, Mle M, Caceres E, et al: Radical mastectomy versus radical mastectomy plus internal mammary dissection. Cancer 51:1941-1943, 1983
18. Veronesi U, Marubini E, Mariani L, et al: The dissection of internal mammary nodes does not improve the survival of breast cancer patients: 30-year results of a randomised trial. Eur J Cancer 35:1320-1325, 1999
19. Gaffney DK, Tsodikov A, Wiggins CL: Diminished survival in patients with inner versus outer quadrant breast cancers. J Clin Oncol 21:467-472, 2003
20. Kroman N, Wohlfahrt J, Mouridesn HT: Influence of tumor location on breast cancer prognosis. Int J Cancer 105:542-545, 2003
21. Host H, Brennhovd IO, Loeb M: Postoperative radiotherapy in breast cancer: Long-term results from the Oslo study. Int J Radiat Oncol Biol Phys 12:727-732, 1986
22. Overgaard M, Hansen PS, Overgaard J, et al: Postoperative radiotherapy in high-risk pre-menopausal women with breast cancer who receive adjuvant chemotherapy: Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med 337:949-955, 1997
23. Overgaard M, Jensen MB, Overgaard J, et al: Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet 353:1641-1648, 1999
24. Ragaz J, Jackson SM, Le N, et al: Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med 337:956-962, 1997
25. Goldhirsch A, Coates AS, Colleoni M: Radiotherapy and chemotherapy in high-risk breast cancer. N Engl J Med 338:330-331, 1998
26. Sacchini V, Borgen PI, Galimberti V, et al: Surgical approach to internal mammary lymph node biopsy. J Am Coll Surg 193:709-713, 2001
27. Eubank WB, Mankoff DA, Takasugi J, et al: 18-fluorodeoxyglucose positron emission tomography to detect mediastinal or internal mammary metastases in breast cancer. J Clin Oncol 19:3516-3523, 2001